Similar companies
Company | Business Outlook | |
---|---|---|
![]() |
AmgenAMGN |
75 0% |
![]() |
Gilead SciencesGILD |
64 0% |
![]() |
Catalyst PharmaceuticalsCPRX |
100 0% |
![]() |
Inovio PharmaceuticalsINO |
19 0% |
![]() |
Crispr TherapeuticsCRSP |
47 0% |
Month over Month
Employee view on business outlook (0 - 100)
May 2024 | 91 | |
Apr 2024 | 87 | |
Mar 2024 | 82 | |
Feb 2024 | 79 |
How do employees feel about the future at BridgeBio Pharma?
The Business Outlook at BridgeBio Pharma is very positive according to its employees. The average outlook rating of 91 (out of 100) is very high according to data from the top review sites in the US.
Analyzing Business Outlook, how is BridgeBio Pharma performing compared to its industry peers?
BridgeBio Pharma overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 91st percentile.
How has the business outlook at BridgeBio Pharma changed over the last couple of months
In recent months, BridgeBio Pharma's employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at BridgeBio Pharma?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at BridgeBio Pharma.